Amylin and epinephrine have no direct effect on glucose transport in isolated rat soleus muscle

FEBS Lett. 1995 May 22;365(1):98-100. doi: 10.1016/0014-5793(95)00449-j.

Abstract

Amylin and epinephrine did not significantly affect insulin stimulated, or basal, 3-O-methylglucose transport in isolated rat soleus muscle, as measured by the release of 3-O-methylglucose from pre-loaded tissue. Both amylin and epinephrine inhibited insulin-stimulated 2-deoxyglucose uptake (by 25% and 38%, respectively) in soleus muscle from fed rats but not from fasted rats. The latter results are consistent with amylin and epinephrine stimulating glycogenolysis and inhibiting hexokinase activity by intracellular accumulation of glucose 6-phosphate. We conclude that amylin, like epinephrine, does not specifically inhibit glucose transporters in skeletal muscle.

MeSH terms

  • 3-O-Methylglucose
  • Amyloid / pharmacology*
  • Animals
  • Biological Transport / drug effects
  • Deoxyglucose / metabolism
  • Epinephrine / pharmacology*
  • Glucose / analogs & derivatives
  • Glucose / metabolism*
  • Glucose-6-Phosphate
  • Glucosephosphates / metabolism
  • Glycogen / metabolism
  • Hexokinase / metabolism
  • In Vitro Techniques
  • Insulin / pharmacology
  • Islet Amyloid Polypeptide
  • Male
  • Methylglucosides / metabolism
  • Muscle, Skeletal / metabolism*
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Amyloid
  • Glucosephosphates
  • Insulin
  • Islet Amyloid Polypeptide
  • Methylglucosides
  • 3-O-Methylglucose
  • Glucose-6-Phosphate
  • Glycogen
  • Deoxyglucose
  • Hexokinase
  • Glucose
  • Epinephrine